Mark S Shearman Editas Medicine, Inc. (EDIT) insider trading activity

EDIT Quotes by TradingView

Mark S Shearman is EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc.. Currently has a direct ownership of 65,559 shares of EDIT, which is worth approximately $159,963. The most recent transaction as insider was on Feb 13, 2023, when has been sold 2,790 shares (Common Stock) at a price of $9.67 per share, resulting in proceeds of $26,979. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.6K
0% 3M change
0% 12M change
Total Value Held $159,963

Mark S Shearman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2023
SELL
Open market or private sale
$26,979 $9.67 p/Share
2,790 Reduced 4.08%
65,559 Common Stock
Jun 15 2022
SELL
Open market or private sale
$51,759 $10.06 p/Share
5,145 Reduced 7.0%
68,349 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
31,709 Added 30.14%
73,494 Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
9,084 Added 17.86%
41,785 Common Stock
Jun 14 2021
BUY
Grant, award, or other acquisition
-
32,701 Added 50.0%
32,701 Common Stock
MSS

Mark S Shearman

EVP, CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDIT